Get started
SOLIGENIX INC COM USD0.001(POST REV SPLT)SOLIGENIX INC COM USD0.001(POST REV SPLT)SOLIGENIX INC COM USD0.001(POST REV SPLT)

SOLIGENIX INC COM USD0.001(POST REV SPLT)

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

0A6I chart


Full chart

0A6I upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪8.81 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−7.80 USD
Net income (FY)
‪−6.14 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪2.51 M‬
Beta (1Y)
1.54

Employees


Employees (FY)
15
Change (1Y)
0
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−409.38 K‬ USD

About Soligenix, Inc.


Sector
Health Technology
CEO
Christopher J. Schaber
Headquarters
Princeton
Website
soligenix.com
Founded
1987
FIGI
BBG00ZHZW7H7
Soligenix, Inc. is a late-stage biopharmaceutical company, which engages in the development and commercialization of products to treat rare diseases. It operates through the Specialized BioTherapeutics and Public Health Solutions segments. The Specialized BioTherapeutics segment focuses on the development of a novel photodynamic therapy (SGX301) utilizing topical synthetic hypericin activated with safe visible fluorescent light for the treatment of cutaneous T-cell lymphoma. The Public Health Solutions segment consists of active development programs for RiVax, a ricin toxin vaccine candidate, and SGX943, a therapeutic candidate for antibiotic resistant and emerging infectious disease. The company was founded in 1987 and is headquartered Princeton, NJ.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

0A6I news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 0A6I is 3.42 USD — it has decreased by −6.03% in the past 24 hours. Watch SOLIGENIX INC COM USD0.001(POST REV SPLT) stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange SOLIGENIX INC COM USD0.001(POST REV SPLT) stocks are traded under the ticker 0A6I.
0A6I stock has fallen by −6.29% compared to the previous week, the month change is a −6.16% fall, over the last year SOLIGENIX INC COM USD0.001(POST REV SPLT) has showed a −48.89% decrease.
0A6I reached its all-time high on Mar 4, 2021 with the price of 540.00 USD, and its all-time low was 1.92 USD and was reached on Jul 8, 2024. View more price dynamics on 0A6I chart.
See other stocks reaching their highest and lowest prices.
0A6I stock is 6.41% volatile and has beta coefficient of 1.54. Track SOLIGENIX INC COM USD0.001(POST REV SPLT) stock price on the chart and check out the list of the most volatile stocks — is SOLIGENIX INC COM USD0.001(POST REV SPLT) there?
Today SOLIGENIX INC COM USD0.001(POST REV SPLT) has the market capitalization of ‪8.81 M‬, it has decreased by −2.75% over the last week.
Yes, you can track SOLIGENIX INC COM USD0.001(POST REV SPLT) financials in yearly and quarterly reports right on TradingView.
SOLIGENIX INC COM USD0.001(POST REV SPLT) is going to release the next earnings report on Apr 1, 2025. Keep track of upcoming events with our Earnings Calendar.
0A6I earnings for the last quarter are −0.78 USD per share, whereas the estimation was −1.39 USD resulting in a 43.88% surprise. The estimated earnings for the next quarter are −0.95 USD per share. See more details about SOLIGENIX INC COM USD0.001(POST REV SPLT) earnings.
SOLIGENIX INC COM USD0.001(POST REV SPLT) revenue for the last quarter amounts to 0.00 USD, despite the estimated figure of ‪200.00 K‬ USD. In the next quarter, revenue is expected to reach ‪200.00 K‬ USD.
0A6I net income for the last quarter is ‪−1.72 M‬ USD, while the quarter before that showed ‪−1.64 M‬ USD of net income which accounts for −4.55% change. Track more SOLIGENIX INC COM USD0.001(POST REV SPLT) financial stats to get the full picture.
No, 0A6I doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 15.00 employees. See our rating of the largest employees — is SOLIGENIX INC COM USD0.001(POST REV SPLT) on this list?
Like other stocks, 0A6I shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SOLIGENIX INC COM USD0.001(POST REV SPLT) stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SOLIGENIX INC COM USD0.001(POST REV SPLT) technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SOLIGENIX INC COM USD0.001(POST REV SPLT) stock shows the sell signal. See more of SOLIGENIX INC COM USD0.001(POST REV SPLT) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.